A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial

CONCLUSION: Resolved clinical symptoms, improved oxygenation, clearance of infiltrates on Chest X-ray and improvement in biomarkers in a short period with non-progression of the disease showed that IV ozonised saline therapy was safe and effective to prevent disease progression in COVID-19, making it an effective novel therapeutic tool.PMID:33984718 | PMC:PMC8084612 | DOI:10.1016/j.intimp.2021.107743

Source: International Immunopharmacology - May 13, 2021 Category: Allergy & Immunology Authors: Alok Sharma Mili Shah Satya Lakshmi Hemangi Sane Jignasha Captain Nandini Gokulchandran Pallavi Khubchandani M K Pradeep Prakash Gote Balaji Tuppekar Pooja Kulkarni Amruta Paranjape Radhika Pradhan Ritu Varghese Sushil Kasekar Vivek Nair Ummeammara Khanba Source Type: research